Clinical Trial Update: Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301 [Phase 3]

View source ↗

Summary

A Phase 3 pediatric ADHD trial evaluating CTx-1301 has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CTx-1301

Snippet

Sponsor: Cingulate Therapeutics | Conditions: ADHD, ADHD - Combined Type | Phase 3 | Status: SUSPENDED